《大行報告》瑞信上調信義玻璃(00868.HK)目標價至35元 評級「跑贏大市」
瑞信發表研究指,信義玻璃(00868.HK)中期純利錄近54億元,爲預期的上限,創新高按年增長289%,主要來自浮法玻璃售價快速上升,令產品毛利率增長亦勝預期。
該行指,上半年信義玻璃售價指數按年升38%,7月份指數更升至2,687點,按年升75%,相信是由於行業庫存處於低水平所致。瑞信預期,即使原材料成本上升,公司浮法玻璃的毛利率於下半年亦將進一步提升至62.5%。
考慮到上半年業績勝預期,該行將2021至2023年純利預測上調22.8%至56.6%,目標價由29元升至35元,維持「跑贏大市」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.